Patients suffering from chronic lung diseases might soon leave symptoms like coughing, chest tightness, and shortness of breath behind. This week, Israel's Sheba Medical Center and the Synchrony Medical startup launched the first clinical trial of Synchrony's personalized chest physiotherapy system designed to provide efficient airway clearance.
Follow Israel Hayom on Facebook and Twitter
Synchrony Medical, a portfolio company of MEDX Xelerator, a medical device incubator formed as an initiative of MEDX Ventures Group together with Boston Scientific, Intellectual Ventures and Sheba Medical Center, has developed a novel airway clearance system based on a unique chest physiotherapy method developed at the National Cystic Fibrosis Center of Israel at Sheba Medical Center. The system includes real-time sensing to allow an adaptive treatment to achieve effective airway clearance.
The trial aims to test the functionality of the system and compare its effectiveness to standard care solutions currently used with patients who suffer from lung diseases, such as cystic fibrosis and bronchiectasis.
"Effective airway clearance on a daily basis at home is the key to keeping chronic lung patients stable and breaking the vicious cycle of clinical deteriorations," said Dr. Moshe Ashkenazi, a pediatric pulmonologist at Sheba Medical Center and co-founder of Synchrony Medical.
"Our system will enable patients to receive state-of-the-art chest physiotherapy independently, in the comfort of their own home," explained Anat Shani, CEO of Synchrony Medical.
"By making this effective therapy accessible, Synchrony Medical will bring to patient's years of experience from Sheba's respiratory experts and may help minimize pulmonary exacerbations and costly hospitalization associated with chronic lung diseases. This trial brings us one step closer to our goal: improving the lives of millions of chronic lung disease patients who deserve better airway clearance solutions."
Subscribe to Israel Hayom's daily newsletter and never miss our top stories!
